Soon Chang Kwon

Title: The Innovations of Soon Chang Kwon in Transdermal Delivery Systems

Introduction

Soon Chang Kwon, based in Daejeon, South Korea, is a prolific inventor with a remarkable portfolio of four patents. His innovative work primarily focuses on the development of microstructures that enhance transdermal absorption, offering significant advancements in drug delivery systems and skin treatment technologies.

Latest Patents

One of Kwon's latest inventions is a microstructure for transdermal absorption and the method for manufacturing it. This invention introduces a microstructure composed of a biocompatible polymer or adhesive. The optimization of aspect ratios for various microstructures ensures optimal tip angles and diameter ranges for effective skin penetration. His B-type to D-type microstructures mitigate resistance caused by skin elasticity during attachment, achieving penetration rates greater than 60% and enhancing the absorption of beneficial ingredients. Additionally, the D-type microstructure boasts a triple structure design that maximizes mechanical strength, facilitating effortless skin penetration. When arranged in a hexagonal configuration, these microstructures can distribute uniform pressure across the entire area of application.

Another notable patent relates to hyaluronic acid microstructures with excellent solubility characteristics. This biodegradable microstructure consists of crosslinked hyaluronic acid, demonstrating superior solubility during skin penetration. The invention allows for controlled dissolution rates, ensuring stable delivery of effective ingredients while regulating their release. This microstructure paves the way for advanced transdermal delivery systems for pharmacologically active materials and skin improvement agents.

Career Highlights

Throughout his career, Soon Chang Kwon has significantly impacted the fields of biotechnology and material science. His expertise is reflected in his numerous patents that aim to revolutionize how effective ingredients are delivered into the skin, enhancing treatment efficacy and user experience.

Collaborations

Kwon has collaborated with prominent companies such as Endoderma Co., Ltd. and Lucky Corporation Co., Ltd., leveraging their resources and networks to bring his innovative concepts to fruition. Additionally, his professional relationships with colleagues like Jae Soo Kim and Sang Jin Park have contributed to his success in the field.

Conclusion

Soon Chang Kwon's contributions to the realm of transdermal delivery systems exemplify the impact of innovative thinking in improving health care technology. His patents not only reflect his dedication to advancing medical applications but also pave the way for enhanced skin treatments and drug delivery methodologies, potentially transforming the industry for years to come.